Status:
COMPLETED
Understanding and Intervening With State Shame and Self-criticism
Lead Sponsor:
University of Waterloo
Conditions:
Self-Criticism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the momentary effects of a one-session intervention (compassion-based, logic-based, or placebo control) on individuals with high or low trait self-critici...
Detailed Description
This clinical trial consists of a two-part online study. Part 1 of this study collects baseline measures and screen out ineligible participants. Part 2 of this study will compare the momentary effects...
Eligibility Criteria
Inclusion
- Inclusion Criteria for SONA participants:
- Participants will be UWaterloo undergraduate students with a SONA account.
- Participants must be able to listen to audio clips (either via device speakers or with headphones) during their study participation.
- Inclusion Criteria for Prolific participants:
- Participants will be adults (i.e., 18-64 years of age) with a Prolific account.
- Participants must be able to listen to audio clips (either via device speakers or with headphones) during their study participation.
- Prolific participants must also be first language English speakers.
- Exclusion Criteria:
- All exclusions will only be made prior to randomization of experimental conditions in Part 2 to abide by Consort guidelines for randomized controlled trials.
- Any duplicate survey completions from the same participant for the same study survey, as indicated by their embedded ID code in their Qualtrics data, will be excluded from analysis. For Part 1, the most complete survey completion for each participant will be retained. For Part 2, the most complete survey completion for each participant will also be retained unless the participant has begun the shame induction exercise. If a participant in Part 2 has begun the shame induction and then completes another submission, they will be excluded.
- Participants who do not complete Part 1 measures required for primary hypotheses will also be excluded from analyses (specifically, participants who do not complete the measures of trait self-criticism and trait self-compassion).
- Participants who complete Part 1 but are not randomized to a condition in Part 2, will be excluded from analyses related to Part 2 variables. We will run ANOVAs and/or non-parametric Kruskal Wallis tests with continuous baseline data as the DVs to test if there are any significant differences between participants who do Part 2 and those who do not. We will also run Fisher-Freeman-Halton exact tests on categorical baseline data to test if there are any significant differences between participants who do Part 2 and those who do not.
- Participants who respond to several scales within the same survey with overly consistent responses (i.e., appear to click the same response for every scale item, even though some are reverse scored, assessed via testing of scale variances) may be excluded from analyses involving that survey. Their data from other surveys will still be retained for other analyses.
- Participants who complete a survey in an unreasonably short or long amount of time compared to the average participant may be excluded from analyses involving that survey. Their data from other surveys will still be retained for other analyses.
- Participants who fail half or more of the attention checks in Part 1, and the first attention check prior to randomization in Part 2 will be excluded from the data.
- Participants who were ineligible or withdrew consent will also be excluded from the data.
- Prolific participants who could not complete the Captcha Verification question or fail one or both of the two bot check questions will also be excluded from the analyses.
- We will inspect the distribution of scores on trait self-criticism and consider excluding extreme outliers with very low or very high scores.
Exclusion
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT06200675
Start Date
October 17 2023
End Date
December 31 2023
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Waterloo
Waterloo, Ontario, Canada, N2L3G1